SDS-Polyacrylamide Gel Electrophoresis of Purified Human Leucocyte Interferon and the Antiviral and Anticellular Activities of the Different Interferon Species

References

1. Berg K. 1977; Sequential antibody affinity chromatography of human leukocyte interferon. Scandinavian Journal of Immunology 6:77–86
   [Google Scholar]
2. Berg K., Heron I. 1980; The complete purification of human leukocyte interferon. Scandinavian Journal of Immunology n:489–502
   [Google Scholar]
3. Berg K., Heron I., Hamilton R. 1978; Purification of human interferons by antibody affinity chromatography, using highly absorbed anti-interferon. Scandinavian Journal of Immunology 8:429–436
   [Google Scholar]
4. Bollin E., Vastola K., Olezek D., Sulkowski E. 1978; The interaction of mammalian interferons with immobilized Cibacrom Blue F3GA: modulation of binding strength. Preparative Biochemistry 8:259–274
   [Google Scholar]
5. Cantell K., Hirvonen S. 1978; Large-scale production of human leukocyte interferon containing 10^s units per ml. Journal of General Virology 39:541–543
   [Google Scholar]
6. Christophersen I. S., Jordan R., Osther K., Lindenberg J., Pedersen P. H., Berg K. 1978; Interferon therapy in neoplastic disease. Acta medica Scandinavica 204:471–476
   [Google Scholar]
7. Dahl H. 1977; Differentiation between antiviral and anticellular effects of interferon. Texas Reports on Biology and Medicine 35:381–387
   [Google Scholar]
8. Dahl H., Degre M. F. 1975; Separation of antiviral activity of human interferon from cell growth inhibitory effect. Nature, London 257:799–801
   [Google Scholar]
9. Gordon A. H. 1969 In Electrophoresis of Proteins in Polyacrylamide and Starch Gels p 64 Amsterdam and London: North-Holland;
   [Google Scholar]
10. Gresser L., Brouty-Boye D., Thomas M. T., Macieira-Coelho A. 1970; Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia Li₂₁₀ cells in vitro by interferon preparations. Proceedings of the National Academy of Sciences of the United States of America 66:1052–1058
    [Google Scholar]
11. Havell E. A., Berman B., Ogburn C. A., Berg K., Paucker K., Vilcek J. 1975; Two antigenically distinct species of human interferon. Proceedings of the National Academy of Sciences of the United States of America 72:2185–2187
    [Google Scholar]
12. Heron L., Berg K. 1978; The actions of interferon are potentiated at elevated temperature. Nature, London 274:508–510
    [Google Scholar]
13. Hilfenhaus J., Damm H., Karges H. E., Manthey K. E. 1976; Growth inhibition of human lympho-blastoid Daudi cells in vitro by interferon preparations. Archives of Virology 51:87–97
    [Google Scholar]
14. Laemmli U. K. 1970; Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
15. Lin L. S., Wiranowska-Stewart M., Chudzio T., Stewart W. E. II 1978; Characterization of the heterogeneous molecules of human interferon. Differences in the cross-species antiviral activities of various molecular populations in human leukocyte interferon. Journal of General Virology 39:125–130
    [Google Scholar]
16. Morser J., Kabayo J. P., Hutchinson D. W. 1978; Differences in sialic content of human interferon. Journal of General Virology 41:175–178
    [Google Scholar]
17. Paucker K., Cantell K., Henle W. 1962; Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells. Virology 17:324–334
    [Google Scholar]
18. Porath J., Carlsson J., Olsson L., Belfrage G. 1975; Metal chelate affinity chromatography, a new approach to protein fractionation. Nature, London 258:598–599
    [Google Scholar]
19. Rubinstein M., Rubinstein S., Familetti P. C., Gross M. S., Miller R. S., Waldman A. A., Pastka S. 1978; Human leukocyte interferon purified to homogeneity. Science 202:1289–1290
    [Google Scholar]
20. Rubinstein M., Rubinstein S., Familletti P. C., Gross M. S., Miller R. S., Waldman A. A., Pestka S. 1978; Humna leukocyte interferon: production, purification to homogeneity and initial characterization. Proceedings of the National Academy of Sciences of the United States of America 76:640–644
    [Google Scholar]
21. Stewart H W. E. 1979a In The Interferon System pp 179–183 Wien and New York: Springer-Verlag;
    [Google Scholar]
22. Stewart H W. E. 1979b In The Interferon System p 238 Wien and New York: Springer-Verlag;
    [Google Scholar]
23. Stewart H W. E., Desmyter J. 1975; Molecular heterogeneity of human leukocyte interferon: two populations differing in molecular weights, requirements for renaturation and cross-species antiviral activity. Virology 67:68–73
    [Google Scholar]
24. Stewart H W. E., Gresser I., Tovey M. G., Bandu M.T., Legoff S. 1976; Identification of the cell multiplication inhibitory factors in interferon preparations as interferons. Nature, London 262:300–302
    [Google Scholar]
25. Stewart H W. E., Lin L. S., Wiranowska-Stewart M., Cantell K. 1978; Elimination of size and charge heterogeneities of human leukocyte interferons by chemical cleavage. Proceedings of the National Academy of Sciences of the United States of America 74:4200–4204
    [Google Scholar]
26. Törmä E., Paucker K. 1976; Purification and characterization of human leukocyte interferon components. Journal of Biological Chemistry 251:4810–4816
    [Google Scholar]
27. Vilcek J., Havell E. A., Yamazaki S. 1976; Antigenic, physicochemical, and biological characterization of human interferon. Annals of the New York Academy of Sciences 284:703–710
    [Google Scholar]